| Title | Risk of endstage liver disease in HIV-viral hepatitis co-infected persons in North America from the early to modern antiretroviral therapy eras. |
| Publication Type | Journal Article |
| Year of Publication | 2016 |
| Authors | Klein, Marina B., Keri N. Althoff, Yuezhou Jing, Bryan Lau, Mari Kitahata, Vincent Lo Re, Gregory D. Kirk, Mark Hull, Nina H. Kim, Giada Sebastiani, Erica Moodie, Michael J. Silverberg, Timothy R. Sterling, Jennifer E. Thorne, Angela Cescon, Sonia Napravnik, Joe Eron, John M. Gill, Amy Justice, Marion G. Peters, James Goedert, Angel Mayor, Chloe L. Thio, Edward R. Cachay, and Richard Moore |
| Corporate Authors | North American AIDS Cohort Collaboration on Research and Design(NA-ACCORD) of IeDEA |
| Journal | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
| Date Published | 2016 Aug 9 |
| ISSN | 1537-6591 |
| Abstract | HIV-infected patients co-infected with Hepatitis B (HBV) and C (HCV) viruses are at increased risk of endstage liver disease (ESLD). Whether modern antiretroviral therapy has reduced ESLD risk is unknown. |
| DOI | 10.1093/cid/ciw531 |
| Alternate Journal | Clin. Infect. Dis. |
